AGI
Agi Greenpac Limited (AGI) Announces Q2 FY 2026-27 Earnings Presentation
AGI Greenpac Limited (AGI) unveils Q2 FY 2026-27 earnings presentation, showcasing growth and expansion plans.
AGI Greenpac Limited (AGI) has announced its earnings presentation for Q2 FY 2026-27, highlighting its growth and expansion plans. As a part of the Somany Impresa Group, AGI continues to build on its legacy as India’s most profitable glass packaging leader. The presentation outlines the company’s diversified portfolio and its journey over four decades of building a leading packaging platform.
Company Overview
AGI Greenpac Limited is an integrated rigid packaging solutions manufacturer. It offers a wide range of glass containers, security caps & closures, and PET bottles & products. The company has recently ventured into the high-potential aluminium can market, leveraging synergies in alcohol and F&B segments.
Growth Journey
AGI has a rich history of diversification and expansion. Starting with the container glass business in 1981, it has grown to become a comprehensive packaging solutions provider. Key milestones include the acquisition of Garden Polymer for PET bottles, the launch of closures business, and the recent foray into aluminium cans.
AGI’s mission is to provide innovative and eco-friendly glass packaging solutions, with a vision to be the most preferred rigid packaging company. The company is guided by values such as integrity, passion, customer focus, employee centricity, innovation, and respect for all.
As AGI moves forward, it plans to enhance its manufacturing capabilities and expand its diversified portfolio to meet the growing needs of the rigid packaging market.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of AGI Greenpac Limited
AGI Greenpac Limited belongs to the Consumer Cyclical › Packaging & Containers sector. Here’s a quick read on where the business and the stock stand today.
AGI rises 8.0% over three months, with buying pressure holding steady. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. The PEG of 1.29 sits close to fair value. The stock is neither a clear buy nor obviously expensive. The stock holds at 70% of its 52-week range with RSI at 44. In other words, neither side has a clear edge right now. The stock rises 8.0% in three months on 5.5% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of AGI Greenpac Limited.
AGI
Agi Greenpac Limited (AGI) Q1 FY27: Revenue Grows 14% to ₹785 Crore, Net Profit Up 12% to ₹99 Crore
AGI Greenpac Limited (NSE: AGI) reports a 14% revenue growth to ₹785 crore and a 12% net profit increase to ₹99 crore for Q1 FY27.
AGI Greenpac Limited (NSE: AGI) announced its financial results for the first quarter ended June 30, 2026, showcasing robust top-line and bottom-line growth. Revenue from operations rose 14% year-on-year to ₹785 crore, while net profit grew 12% to ₹99 crore. EBITDA excluding other income stood at ₹175 crore, up 23% over the same period last year, with EBITDA margins expanding to a healthy 22%.
Operational Expansion
Driven by rising domestic and international demand, AGI Greenpac continues to advance its capacity expansion strategy. The company has scaled its daily glass packaging capacity from 1,754 tonnes per day (TPD) to 2,100 TPD through facility debottlenecking as of March 2026. The upcoming Greenfield plant in Madhya Pradesh will unlock an additional 500 TPD over the next 7 to 8 months, lifting total daily capacity to 2,600 TPD, representing a cumulative growth of 48% over the 30 months ending March 2027.
Strategic Initiatives
The company’s strategic foray into the fast-growing aluminium beverage cans segment remains on schedule, with commercial operations targeted to launch by December 2027. This move aims to capture strong cross-segment packaging synergies across alcobev and food and beverage portfolios.
Commenting on the financial results and operational milestones, Mr. Sandip Somany, Chairman and Managing Director, AGI Greenpac Limited, said: ‘Our Q1 FY27 performance reflects the inherent strength of our core business, driven by an improved product mix, enhanced operational efficiencies, and sustained demand across our alcobev, food & beverage, and specialty glass categories. While regional escalations in West Asia put pressure on energy and raw material costs during the quarter —temporarily weighing on margins —our team successfully cushioned the impact through proactive cost-optimization measures. We expect margin performance to strengthen in the coming quarters as input cost volatility eases and the compounding benefits of our efficiency programs take full effect.’
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of AGI Greenpac Limited
AGI Greenpac Limited belongs to the Consumer Cyclical › Packaging & Containers sector. Here’s a quick read on where the business and the stock stand today.
AGI rises 9.5% over three months, with buying pressure holding steady. Revenue consistency is the one bright spot — zero dips in five years shows operational resilience. The PEG of 1.23 sits close to fair value. The stock is neither a clear buy nor obviously expensive. Buyers show up with 1.8x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. The stock rises 9.5% in three months on 5.7% revenue growth. As a result, the market gives it more credit than the fundamentals strictly justify. Watch the next quarterly results. If growth accelerates, the move makes sense. If not, expect some gains to unwind. Check Fundamentals of AGI Greenpac Limited.
-
COFORGE2 days agoCoforge Limited (NSE: Coforge) Named Leader in Everest Group QE Services for AI Applications and Systems PEAK Matrix® Assessment 2026
-
Consumer Defensive2 days agoLt Foods Limited Launches Campaign for Rozana with Celebrity Chef Ranveer Brar
-
Conglomerates2 days agoDcm Shriram Limited (dcmshriram) Q2 FY27: 22% Revenue Growth at ₹3,977 Crore
-
Healthcare2 days agoSudeep Pharma Limited (sudeepphrm) FDA Approval Enables New Pharma Greenfield Facility Operations
-
Healthcare2 days agoSakar Healthcare Limited (sakar): Delivers a Strong Quarter, with Revenue Growth of 53% and Ebitda Growth of 114% Yoy
-
Basic Materials2 days agoChemcon Speciality Chemicals Limited Q2 FY27: Revenue Up 22%, PAT Surges 31%
-
RAYMONDREL2 days agoRaymond Realty Limited (raymondrel) Secures ₹210 Crore Investment for Ten X Realty West
-
BRIGHOTEL2 days agoBrigade Hotel Ventures Limited (brighotel) Q2 FY27: PAT More Than Doubles
